Citadel Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.2M | Sell |
|
|||||
|
2025
Q2 | $62.7M | Buy |
|
|||||
|
2025
Q1 | $265K | Sell |
|
|||||
|
2024
Q4 | $4.59M | Sell |
|
|||||
|
2024
Q3 | $11.6M | Buy |
|
|||||
|
2024
Q2 | $3.13M | Sell |
|
|||||
|
2024
Q1 | $6.57M | Buy |
|
|||||
|
2023
Q4 | $2.43M | Sell |
|
|||||
|
2023
Q3 | $40.4M | Buy |
|
|||||
|
2023
Q2 | $19.4M | Sell |
|
|||||
|
2023
Q1 | $32.5M | Sell |
|
|||||
|
2022
Q4 | $49.4M | Buy |
|
|||||
|
2022
Q3 | $2.74M | Sell |
|
|||||
|
2022
Q2 | $3.77M | Sell |
|
|||||
|
2022
Q1 | $5.83M | Sell |
|
|||||
|
2021
Q4 | $5.21M | Buy |
|
|||||
|
2021
Q3 | $2.57M | Sell |
|
|||||
|
2021
Q2 | $15.7M | Sell |
|
|||||
|
2021
Q1 | $25.7M | Buy |
|
|||||
|
2020
Q4 | $799K | Sell |
|
|||||
|
2020
Q3 | $14.9M | Buy |
|
|||||
|
2020
Q2 | $5.85M | Sell |
|
|||||
|
2020
Q1 | $4.77M | Buy |
|
|||||
|
2019
Q4 | $3.79M | Sell |
|
|||||
|
2019
Q3 | $5.18M | Sell |
|
|||||
|
2019
Q2 | $11.2M | Buy |
|
|||||
|
2019
Q1 | $1.65M | Buy |
|
|||||
|
2018
Q4 | $1.12M | Sell |
|
|||||
|
2018
Q3 | $2.62M | Buy |
|
|||||
|
2018
Q2 | $3.21M | Sell |
|
|||||
|
2018
Q1 | $22.3M | Sell |
|
|||||
|
2017
Q4 | $35M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $332K | Sell |
|
|||||
|
2016
Q2 | $244K | Buy |
|
|||||
|
2016
Q1 | $220K | Sell |
|
|||||
|
2015
Q4 | $429K | Buy |
|
|||||
|
2015
Q3 | $7K | Sell |
|
|||||
|
2015
Q2 | $87K | Sell |
|
|||||
|
2015
Q1 | $411K | Buy |
|
|||||
|
2014
Q4 | $552K | Buy |
|
|||||
|
2014
Q3 | $127K | Sell |
|
|||||
|
2014
Q2 | $249K | Buy |
|
|||||
|
2014
Q1 | $12K | Sell |
|
|||||
|
2013
Q4 | $833K | Buy |
|
|||||
|
2013
Q3 | $231K | Sell |
|
|||||
|
2013
Q2 | $231K | Buy |
|